Mode
Text Size
Log in / Sign up

Mitochondrial dysfunction and post-translational modifications drive progression of radiation-induced heart diseaseNew targets identified to treat radiation induced heart disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that mitochondrial dysfunction and specific post-translational modifications are key drivers in the progression of RIHD.

This systematic review explores the mechanisms underlying radiation-induced heart disease (RIHD), specifically focusing on mitochondrial dysfunction as a central link between early injury and late cardiac remodeling. The authors synthesize evidence regarding several key processes, including mtDNA damage, respiratory chain impairment, sustained mitochondrial reactive oxygen species (mitoROS) accumulation, metabolic network remodeling, and defective mitophagy.

Furthermore, the review highlights how post-translational modifications such as acetylation, SUMOylation, and lactylation regulate mitochondrial processes and contribute to RIHD progression. The authors identify specific molecular targets including NDP52, ATP5F1C, P4HB, and SH3GLB1, alongside bioactive compounds like aloe-emodin and astragaloside IV, which are proposed as potential therapeutic interventions.

A primary limitation noted is that the majority of current evidence is derived from adult models. Consequently, clinical application remains speculative. The review concludes by highlighting a significant research gap regarding the specific needs and outcomes for childhood cancer survivors.

How this fits prior evidence

This systematic review addresses a gap in understanding the molecular mechanisms of radiation-induced heart disease. While previous coverage included preclinical interventions for heat stroke pathophysiology and herbal compounds for membranous nephropathy, this review specifically focuses on mitochondrial homeostasis and post-translational modifications as drivers of cardiac remodeling following radiation.

Radiation can cause lasting damage to the heart, a condition known as radiation-induced heart disease. This type of injury is a serious concern for many patients who undergo radiation therapy. Recent research has pinpointed exactly how this damage happens at a cellular level. It focuses on the mitochondria, which are the powerhouses of our cells. When these units fail, it can lead to long-term changes in heart structure and function.

The study highlights several specific processes that contribute to this decline, such as damaged mitochondrial DNA and an buildup of harmful molecules called reactive oxygen species. These issues disrupt how the heart manages energy and repairs itself. The research also identified specific chemical modifications, like acetylation and lactylation, that play a role in how the disease progresses.

While much of the current evidence comes from adult models, these findings point toward promising targets for future treatment. Specifically, certain proteins and natural compounds like aloe-emodin and astragaloside IV show potential as ways to intervene. However, more research is needed to confirm these effects and to specifically study how these treatments might help children who survive cancer.

What this means for you:
Specific cellular targets and compounds have been identified that may help treat heart damage from radiation.

Common questions

What causes the heart damage in this study?

The research shows that radiation causes a persistent disruption of mitochondrial homeostasis. This means the powerhouses of the cells are damaged, leading to issues like respiratory chain impairment and an accumulation of reactive oxygen species (mitoROS). These problems link early injuries to long-term changes in heart structure.

What specific compounds might help treat this condition?

The study identifies two bioactive compounds, aloe-emodin and astragaloside IV, as potential targets for treatment. Additionally, several proteins including NDP52, ATP5F1C, P4HB, and SH3GLB1 are identified as emerging molecular targets that could be used to intervene in radiation-induced heart disease.

Is this research applicable to children?

Most of the current evidence comes from adult models. Because of this, the researchers highlighted a specific need for more studies focused on childhood cancer survivors to see how these findings apply to younger patients.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedAug 2026
View Original Abstract ↓
BackgroundRadiation-induced heart disease (RIHD) is a major late complication of thoracic radiotherapy. However, the mechanisms responsible for its long-term progression remain poorly understood. Conventional explanations, such as DNA damage, and oxidative stress, mainly focus on early radiation responses and fail to fully account for the prolonged latency and progressive myocardial remodeling observed in RIHD over years to decades.Main contentThis review proposes that persistent disruption of mitochondrial homeostasis represents a central link between early radiation-induced injury and late cardiac remodeling. We systematically summarize the major processes involved in radiation-induced mitochondrial dysfunction. These processes include mtDNA damage, respiratory chain impairment, sustained mitochondrial reactive oxygen species (mitoROS) accumulation, metabolic network remodeling, and defective mitochondrial clearance through mitophagy. We further discuss how acetylation, SUMOylation, and lactylation regulate these processes and contribute to the development and progression of RIHD. Building on this framework, we highlight emerging molecular targets, including NDP52, ATP5F1C, P4HB, and SH3GLB1, as well as the potential protective effects of bioactive compounds derived from traditional Chinese medicine, such as aloe-emodin and astragaloside IV, through restoration of mitochondrial homeostasis. By integrating mitochondrial dysfunction, post-translational modifications, and mitophagy into a unified pathological framework, this review provides new perspectives for early identification and therapeutic intervention in RIHD.Key conclusionsRIHD is not simply an oxidative stress-driven disorder but rather a chronic remodeling process shaped by the interplay among mitochondrial injury, post-translational modifications, and mitophagy dysregulation. This integrated framework links early subcellular alterations to late cardiac remodeling and provides a potential biological explanation for the long latency and progressive nature of RIHD. However, most current evidence is derived from adult models. Future research should specifically address childhood cancer survivors, as radiation exposure during critical periods of cardiac development may result in distinct long-term cardiovascular outcomes.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.